ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Meridian Gold

Meridian Gold (MDG)

0.00
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MDG Latest News

Medigene acquires Trianta Immunotherapies

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene acquires Trianta...

Medigene übernimmt Trianta Immunotherapies

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene übernimmt Trianta...

Medigene's drug Veregen® launched in Norway and Sweden

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene's drug Veregen®...

Medigenes Medikament Veregen® kommt in Norwegen und Schweden auf den Markt

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigenes Medikament Veregen® kommt...

Medigene Granted Additional Patent for RhuDex® for the Treatment of Autoimmune Diseases

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene Granted Additional Patent...

Medigene erhält weiteres europäisches Patent für Autoimmun-Medikamentenkandidaten RhuDex®

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene erhält weiteres europäisches...

Medigene announces Veregen® to be launched in the Czech Republic, Poland, Hungary, and Slovakia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene announces Veregen® to be...

Medigene kündigt Markteinführung von Veregen® in Tschechien, Polen, Ungarn und der Slowakei an

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Medigene kündigt Markteinführung von...

Taurus becomes new marketing partner for Medigene's drug Veregen® in Germany

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Taurus becomes new marketing partner...

Taurus wird neuer Partner für Medigenes Medikament Veregen® in Deutschland

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}Medigene AG / Taurus wird neuer Partner für...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

MDG - Frequently Asked Questions (FAQ)

What is the current Meridian Gold share price?
The current share price of Meridian Gold is US$ 0.00
What is the 1 year trading range for Meridian Gold share price?
Meridian Gold has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LXULSB Industries Inc
US$ 8.95
(20.30%)
310.28k
AGLAgilon Health inc
US$ 2.8898
(18.92%)
2.02M
NVRONevro Corp
US$ 3.90
(18.54%)
482.56k
PDXPIMCO Dynamic Income Strategy Fund
US$ 29.25
(13.64%)
2.53M
AMWLAmerican Well Corporation
US$ 8.14
(12.74%)
32.44k
QBTSD Wave Quantum Inc
US$ 4.205
(-27.12%)
45.01M
ANFAbercrombie and Fitch Co
US$ 129.86
(-19.30%)
3.28M
STEMStem Inc
US$ 0.6698
(-18.39%)
8.08M
FUBOfuboTV
US$ 4.44
(-13.11%)
29.87M
AMPXAmprius Technologies Inc
US$ 3.145
(-12.40%)
1.68M
QBTSD Wave Quantum Inc
US$ 4.205
(-27.12%)
45.01M
FUBOfuboTV
US$ 4.44
(-13.11%)
29.87M
IONQIonQ Inc
US$ 29.21
(-9.65%)
27.63M
FFord Motor Company
US$ 9.645
(-0.05%)
15.42M
NIONIO Inc
US$ 4.0787
(-2.19%)
14.78M

Discussion

View Full Feed
Truth and Transparency Truth and Transparency 1 minute ago
Buy more shares now to bring your overall share price down. Great buying opportunity at these decade lows. Don’t look a gift horse in the mouth. Be thankful, not critical…..lol

Of course, im being very sarcastic. Mark Smith and his dream team have failed the investors who have support
NB
DewDiligence DewDiligence 1 minute ago
Thanks. I may have stretched by pigeonholing the GSK deal as immunology, but it does bring the potential for GSK to expand into KIT immunology, as you noted.
ENTA
The Penny Preacher The Penny Preacher 1 minute ago
SNL has nothing on the Hub.

Best entertainment forum on the web.

TPP
trunkmonk trunkmonk 1 minute ago
Those meds do wonders.
FNMA
Hi_Lo Hi_Lo 1 minute ago
Like I said last week - this small BS run is over. There was no reason for it to begin with.

This will be back to .001 - .002 in no time.

GVSI is a regulatory disaster and a scam.
GVSI
ace65 ace65 2 minutes ago
WE READY ?...7 mil.buy at .0003 just hit..need more chunky buys.
TKMO
BluE33 BluE33 2 minutes ago
That Fontalk website looks very impressive!
ASII
BRoberts1982 BRoberts1982 2 minutes ago
The day by day of non news will be a slow drop in CLNV price.
The CLNV price drop will speed up as the end of the month gets closer
CLNV will be hitting .015 range next.

If we start February and there is NO NEWS then CLNV should expect
CLNV price back to LOW teen
CLNV
firebag1 firebag1 2 minutes ago
nice news
LITM
Rambo Rell Rambo Rell 2 minutes ago
$ILLR: AI-Driven Innovation
With cutting-edge AI integrations, Triller is providing creators unparalleled tools to amplify their reach and engagement. Invest in technology. Invest in Triller. #AIFuture #ILLR
ILLR
dexprs dexprs 2 minutes ago
Sold NVDA 10 Puts, would have liked to sell 15, but I do not like the trend for the short term.
NVDA
Rambo Rell Rambo Rell 2 minutes ago
$ILLR: AI-Driven Innovation
With cutting-edge AI integrations, Triller is providing creators unparalleled tools to amplify their reach and engagement. Invest in technology. Invest in Triller. #AIFuture #ILLR
ILLR
Rambo Rell Rambo Rell 3 minutes ago
$ILLR: Monetization at Its Core
Our focus on enhancing monetization tools gives creators a platform to turn their passion into profit. Triller is the backbone of creator success. #InvestSmart #ILLR
ILLR
Rambo Rell Rambo Rell 3 minutes ago
$ILLR: Monetization at Its Core
Our focus on enhancing monetization tools gives creators a platform to turn their passion into profit. Triller is the backbone of creator success. #InvestSmart #ILLR
ILLR
axelvento axelvento 3 minutes ago
Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited)

Updates 2025 expected revenue range to $1.5 to 2.5 billion

Expects to reduce 2025 cash cost expenses by $1.0 billion with a plan for addit
MRNA
halbroke1 halbroke1 3 minutes ago
UMAV $$$ SO CRAZY UNDERVALUED HERE.....SHOULD BE HEADING TO MULTI-DOLLARS....WAIT TILL TRUMP GETS IN THE MARKETS WILL GO CRAZY, TO THE MOON..
UMAV
fung_derf fung_derf 4 minutes ago
Great post! There are some good stocks you've mentioned and some worth looking further into.
FWIW, I've probably never listed every stock I own. Many that you list I've either owned in the past or still do. I am quite diverse. Of the ones you listed, I currently own (and in the same industry)
TPL UFPI UGI
Stino2 Stino2 4 minutes ago
is there someone home here?
PHUN
getmoreshares getmoreshares 4 minutes ago
33m ask at 5
CGAC
Number sleven Number sleven 4 minutes ago
Kiwi, I own eypt. Phase 2 trial ends this month. Should be positive. The phase 3 that ocular is running should also be positive. Based on the phase 1 results. Considering a trade.
Sleven,
OCUL
eagle8 eagle8 4 minutes ago
Yes indeed and with a revenue of $4 billion in the near future (within 1 to 2 years) an MC of almost $100 billion.
And in anticipation of this turnover an MC of $35 billion after approval is not so crazy.
Not bad either, right?
Just keep shorting, then at least you know what to
NWBO
DDA DDA 4 minutes ago
Knowing this is a low floater ... estimated 50-70 million max. ... someone is collecting.


1 Jan 2025
0.00975
0.00375
62.50%
0.0081
0.00975
0.0041
654,861

1 Jan 2024
0.006
0.00245
69.01%
STGZ
Renee Renee 4 minutes ago
LFAP SEC registration revoked:

https://www.sec.gov/files/litigation/opinions/2025/34-102149.pdf
LFAP
JusDePomme JusDePomme 5 minutes ago
Someone sold to me .0004 more...goodness volume
AFFU

Your Recent History

Delayed Upgrade Clock